LY300503
LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 148905-79-7
- Fòrmula: C14H16ClNO
- Peso molecular:249.74
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 148905-79-7
-
Peso molecular 249.74
-
Fòrmula C14H16ClNO
-
SMILES
CN1[C@]2([H])[C@](CCC1=O)([H])C3=CC=C(Cl)C=C3CC2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Farid NA, et, al. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY191704, a human type 1 5 alpha-reductase inhibitor, in plasma. J Chromatogr B Biomed Sci Appl. [Content Brief]
[2]. Farid NA, et, al. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs. Drug Metab Dispos. 1996 Oct;24(10):1162-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)